RHO and cancer: Increased cancer aggressiveness in case of ROCK1 and/or RhoA overexpression fits very well with the known role of the Rho/Rock signaling pathway as a regulator of the actin cytoskeleton dynamics, and therefore, of various critical tumor-relevant processes such as cell motility, growth, dell division and cell survival.